BANK VONTOBEL/CALL/PFIZER INC/33/0.1/17.01.25 Share Price

Warrant

DE000VM9BX56

Real-time Boerse Frankfurt Warrants 05:31:18 04/07/2024 pm IST
0.056 EUR +7.69% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/33/0.1/17.01.25
Current month-11.86%
1 month-49.51%
Date Price Change
04/24/04 0.056 +7.69%
03/24/03 0.052 -8.77%
02/24/02 0.057 -12.31%
01/24/01 0.065 +10.17%
28/24/28 0.059 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 05:31 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9BX5
ISINDE000VM9BX56
Date issued 30/01/2024
Strike 33 $
Maturity 17/01/2025 (197 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.131
Lowest since issue 0.04
Delta0.22x
Omega 9.195
Premium21.55x
Gearing41.38x
Moneyness 0.8394
Difference Strike 5.3 $
Difference Strike %+16.06%
Spread 0.01
Spread %14.93%
Theoretical value 0.0600
Implied Volatility 27.76 %
Total Loss Probability 83.25 %
Intrinsic value 0.000000
Present value 0.0600
Break even 33.65 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus